Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS: ELTP · Delayed Price · USD
0.190
-0.002 (-1.09%)
Jul 23, 2024, 4:00 PM EDT - Market open
Elite Pharmaceuticals Employees
Elite Pharmaceuticals had 64 employees as of March 31, 2024. The number of employees increased by 11 or 20.75% compared to the previous year.
Employees
64
Change (1Y)
11
Growth (1Y)
20.75%
Revenue / Employee
$884,768
Profits / Employee
$314,197
Market Cap
202.97M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
| Danaher | 63,000 |
ELTP News
- 22 days ago - Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information - Newsfile Corp
- 27 days ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024 - Newsfile Corp
- 2 months ago - Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate - Accesswire
- 5 months ago - Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information - Accesswire
- 5 months ago - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024 - Accesswire
- 7 months ago - Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant - Accesswire
- 8 months ago - Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLC - Accesswire
- 9 months ago - Elite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Information - Accesswire